The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome.

[1]  J. M. Brown,et al.  Mammalian alpha beta hydrolase domain (ABHD) proteins: Lipid metabolizing enzymes at the interface of cell signaling and energy metabolism. , 2013, Biochimica et biophysica acta.

[2]  G. Siuzdak,et al.  ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC , 2013, Proceedings of the National Academy of Sciences.

[3]  Thierry Hotelier,et al.  ESTHER, the database of the α/β-hydrolase fold superfamily of proteins: tools to explore diversity of functions , 2012, Nucleic Acids Res..

[4]  Carsten Bergmann,et al.  Targeted next-generation sequencing identifies a homozygous nonsense mutation in ABHD12, the gene underlying PHARC, in a family clinically diagnosed with Usher syndrome type 3 , 2012, Orphanet Journal of Rare Diseases.

[5]  Alka Malhotra,et al.  Evidence for a Role of LPGAT1 in Influencing BMI and Percent Body Fat in Native Americans , 2012, Obesity.

[6]  J. Moffat,et al.  A genome wide shRNA screen identifies α/β hydrolase domain containing 4 (ABHD4) as a novel regulator of anoikis resistance , 2012, Apoptosis.

[7]  M. S. Miller,et al.  A Gated-7T MRI Technique for Tracking Lung Tumor Development and Progression in Mice after Exposure to Low Doses of Ionizing Radiation , 2012, Radiation research.

[8]  J. Laitinen,et al.  The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors , 2012, Acta physiologica.

[9]  Yurii S. Aulchenko,et al.  Genome-Wide Association Study Identifies Novel Loci Associated with Circulating Phospho- and Sphingolipid Concentrations , 2012, PLoS genetics.

[10]  Richard G. Lee,et al.  CGI-58/ABHD5-Derived Signaling Lipids Regulate Systemic Inflammation and Insulin Action , 2012, Diabetes.

[11]  H. Brown,et al.  Quantitative analysis of glycerophospholipids by LC-MS: acquisition, data handling, and interpretation. , 2011, Biochimica et biophysica acta.

[12]  K. Mackie,et al.  COX‐2 and fatty acid amide hydrolase can regulate the time course of depolarization‐induced suppression of excitation , 2011, British journal of pharmacology.

[13]  J. Long,et al.  The metabolic serine hydrolases and their functions in mammalian physiology and disease. , 2011, Chemical reviews.

[14]  G. Siuzdak,et al.  Metabolomics annotates ABHD3 as a physiologic regulator of medium-chain phospholipids , 2011, Nature chemical biology.

[15]  R. Vancini,et al.  Structural mutants of dengue virus 2 transmembrane domains exhibit host-range phenotype , 2011, Virology Journal.

[16]  M. Mclaughlin,et al.  Distinct p53 Transcriptional Programs Dictate Acute DNA-Damage Responses and Tumor Suppression , 2011, Cell.

[17]  Jing Yang,et al.  Antisense oligonucleotides targeting abhydrolase domain containing 2 block human hepatitis B virus propagation. , 2011, Oligonucleotides.

[18]  R. Zechner,et al.  Monoglyceride Lipase Deficiency in Mice Impairs Lipolysis and Attenuates Diet-induced Insulin Resistance* , 2011, The Journal of Biological Chemistry.

[19]  Sherry L. Niessen,et al.  Superfamily-wide portrait of serine hydrolase inhibition achieved by library-versus-library screening , 2010, Proceedings of the National Academy of Sciences.

[20]  John T. Melchior,et al.  CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance[S] , 2010, Journal of Lipid Research.

[21]  N. Drouot,et al.  Mutations in ABHD12 cause the neurodegenerative disease PHARC: An inborn error of endocannabinoid metabolism. , 2010, American journal of human genetics.

[22]  Peter T. Nguyen,et al.  Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system , 2010, Nature Neuroscience.

[23]  Agnes L. Bodor,et al.  The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors , 2010, Nature Neuroscience.

[24]  Vidya Subramanian,et al.  CGI-58/ABHD5 is a coenzyme A-dependent lysophosphatidic acid acyltransferase , 2010, Journal of Lipid Research.

[25]  J. Aoki,et al.  Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine and lysophosphatidylglycerol. , 2009, Prostaglandins & other lipid mediators.

[26]  R. Zechner,et al.  Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5. , 2009, American journal of physiology. Endocrinology and metabolism.

[27]  D. Nomura,et al.  Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism. , 2009, Chemistry & biology.

[28]  T. Hla,et al.  Lysophospholipid receptors in vertebrate development, physiology, and pathology Published, JLR Papers in Press, December 8, 2008. , 2009, Journal of Lipid Research.

[29]  D. Gardner,et al.  Transcriptome analysis of in vivo and in vitro matured bovine MII oocytes. , 2009, Theriogenology.

[30]  P. He,et al.  Age-related pulmonary emphysema in mice lacking alpha/beta hydrolase domain containing 2 gene. , 2009, Biochemical and biophysical research communications.

[31]  Heather M. Alger,et al.  Inhibition of Stearoyl-Coenzyme A Desaturase 1 Dissociates Insulin Resistance and Obesity From Atherosclerosis , 2008, Circulation.

[32]  R. Rajasekharan,et al.  CGI-58, the Causative Gene for Chanarin-Dorfman Syndrome, Mediates Acylation of Lysophosphatidic Acid* , 2008, Journal of Biological Chemistry.

[33]  G. Marsicano,et al.  Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. , 2008, The Journal of clinical investigation.

[34]  Sun Young Lee,et al.  Lysophosphatidylglycerol stimulates chemotactic migration in human natural killer cells. , 2008, Biochemical and biophysical research communications.

[35]  Thomas L. Smith,et al.  Targeted Depletion of Hepatic ACAT2-driven Cholesterol Esterification Reveals a Non-biliary Route for Fecal Neutral Sterol Loss* , 2008, Journal of Biological Chemistry.

[36]  R. Schneiter,et al.  Lipid signalling in disease , 2008, Nature Reviews Molecular Cell Biology.

[37]  R. Palmiter,et al.  Multiple pathways involved in the biosynthesis of anandamide , 2008, Neuropharmacology.

[38]  K. Yamamura,et al.  Elevated mature macrophage expression of human ABHD2 gene in vulnerable plaque. , 2008, Biochemical and biophysical research communications.

[39]  B. Cravatt,et al.  A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2‐Arachidonoylglycerol , 2007, Chemistry & biology.

[40]  M. Lagarde,et al.  De novo biosynthesis of the late endosome lipid, bis(monoacylglycero)phosphates⃞ Published, JLR Papers in Press, June 8, 2007. , 2007, Journal of Lipid Research.

[41]  B. Cravatt,et al.  A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases. , 2007, Journal of the American Chemical Society.

[42]  Petra C. Kienesberger,et al.  Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome. , 2006, Cell metabolism.

[43]  David J Beech,et al.  Sensing of Lysophospholipids by TRPC5 Calcium Channel* , 2006, Journal of Biological Chemistry.

[44]  K. Mackie,et al.  Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. , 2005, The Journal of clinical investigation.

[45]  M. Graham,et al.  An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis Published, JLR Papers in Press, February 16, 2005. DOI 10.1194/jlr.M400492-JLR200 , 2005, Journal of Lipid Research.

[46]  T. Suda,et al.  Increase of smooth muscle cell migration and of intimal hyperplasia in mice lacking the α/β hydrolase domain containing 2 gene , 2005 .

[47]  Takao Shimizu,et al.  G2A Is a Proton-sensing G-protein-coupled Receptor Antagonized by Lysophosphatidylcholine* , 2004, Journal of Biological Chemistry.

[48]  P. Tso,et al.  A novel, noninvasive method for the measurement of intestinal fat absorption. , 2004, Gastroenterology.

[49]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[50]  J. Weissenbach,et al.  Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. , 2001, American journal of human genetics.

[51]  N. Nagan,et al.  Plasmalogens: biosynthesis and functions. , 2001, Progress in lipid research.

[52]  M. Nardini,et al.  α/β Hydrolase fold enzymes : the family keeps growing , 1999 .

[53]  R. Coleman,et al.  Neutral lipid storage disease with fatty liver and cholestasis. , 1997, Journal of pediatric gastroenterology and nutrition.

[54]  R. Hammer,et al.  Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. , 1996, The Journal of clinical investigation.

[55]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[56]  H. Callender,et al.  Quantification of diacylglycerol species from cellular extracts by electrospray ionization mass spectrometry using a linear regression algorithm. , 2007, Analytical chemistry.

[57]  H. Brown,et al.  Glycerophospholipid identification and quantitation by electrospray ionization mass spectrometry. , 2007, Methods in enzymology.

[58]  T. Suda,et al.  Increase of smooth muscle cell migration and of intimal hyperplasia in mice lacking the alpha/beta hydrolase domain containing 2 gene. , 2005, Biochemical and biophysical research communications.

[59]  Thierry Hotelier,et al.  ESTHER, the database of the alpha/beta-hydrolase fold superfamily of proteins. , 2004, Nucleic acids research.

[60]  S. Mandrup,et al.  Conjugated linoleic acid (CLA) induces human adipocyte delipidation: autocrine/paracrine regulation of MEK/ERK signaling by adipocytokines , 2004 .

[61]  M. Nardini,et al.  Alpha/beta hydrolase fold enzymes: the family keeps growing. , 1999, Current opinion in structural biology.

[62]  S. Crooke.  Advances in understanding the pharmacological properties of antisense oligonucleotides. , 1997, Advances in pharmacology.

[63]  S. Grundy,et al.  Method to measure apolipoprotein B-48 and B-100 secretion rates in an individual mouse: evidence for a very rapid turnover of VLDL and preferential removal of B-48- relative to B-100-containing lipoproteins. , 1996, Journal of lipid research.